<!DOCTYPE HTML>
<html>
  <head>
    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8">
    <title>Paroxetine CR (Paxil CR)</title>

	</head>
  <body onLoad="init();">
    <div data-role="page" data-theme="b">
  	<div data-role="header" data-theme="b" data-position="fixed">
    	<h1>Paroxetine CR</h1> 
    	<a href="#" data-rel="back" data-icon="arrow-l" data-theme="b" data-direction="reverse" >Back</a>
	</div>
    <div data-role="content">
<h3>Brand name: Paxil CR</h3>
<hr>
					<h3>Adult Starting Dose (Max Per Day)</h3>	
					<ul>
						<li>Initial adult dose = 25mg QD </li>
						<li>Max adult dose/day = 62.5mg QD</li>
						<li>Initial geriatric dose = 12.5mg QD</li>
						<li>Max geriatric dose = 50mg daily QD</li>
					</ul>
<hr>
					<h3>Advantages</h3>	
					<ul>
						<li>May be taken with or without food.</li>
						<li>AM daily dosing</li>
						<li>Do not crush or chew CR tab</li>
						<li>Generic</li>
					</ul>
<hr>
					<h3>Disadvantages</h3>	
					<ul>
						<li>Of the SSRIs, highest reported rate of discontinuation syndrome, highest rate of sexual dysfunction and weight gain</li>
						<li>Sometimes sedating and more anti-cholinergic symptoms</li>
						<li>Possibly more CYP450 interactions</li>
					</ul>
<hr>
					<h3>Pregnancy Category</h3>	
					<ul>
						<li>Positive evidence of risk; However potential benefits may outweigh potential risks</li>
					</ul>
<hr>
					<h3>Safety Margin for SSRIs</h3>	
					<ul>
						<li>Wide margin of safety, rare deaths reported on over dose</li>
						<li>Contraindicated with pimozide or with MAOIs within two weeks of discontinuing MAOIs</li>
						<li>Fluoxetine or paroxetine contraindicated with thioridazine within five weeks of discontinuing therapy</li>
						<li>Contraindicated sertraline oral concentrate with disulfiram</li>
						<li>Do not take citalopram and escitalopram concomitantly</li>
						<li>Do not initiate concomitant therapy with a benzodiazepine</li>
						<li>Drug interactions may include Tricyclic Antidepressants, NSAIDs, SNRIs, Triptans, aspirin, carbamazepine, warfarin, nilotinib, sibutramine, tamoxifen, tetrabenazine and ziprasidone</li>
						<li>Avoid concomitant use with alcohol, l-tryptophan and st. john's wort</li>
						<li>Taper dose slowly to prevent clinically significant discontinuation symptoms</li>
					</ul>
<hr>
					<h3>Efficacy for SSRIs</h3>	
					<ul>
						<li>Depression: Response rate: mild depression = 4-8 weeks; Moderate depression = 8-12 week; Severe depression = augmentative strategies, concurrent administration of adjuncts (referral to specialist)</li> 
						<li>Recommended as monotherapy as first-line therapy in PTSD </li>
						<li>PTSD: Paroxetine IR and sertraline approved for use in PTSD; Efficacy for long-term use in PTSD has not been systematically evaluated</li>
						<li>Escitalopram and fluoxetine have good documentation for off-label use in PTSD</li>
					</ul>
<hr>
<a href="../adverse_effects.html" data-role="button">Adverse Effects</a>
    </div><!-- end jqm content -->
   
    </div><!-- end jqm page -->
  </body>
</html>
